FI874804A0 - Bicykliska foereningar. - Google Patents

Bicykliska foereningar.

Info

Publication number
FI874804A0
FI874804A0 FI874804A FI874804A FI874804A0 FI 874804 A0 FI874804 A0 FI 874804A0 FI 874804 A FI874804 A FI 874804A FI 874804 A FI874804 A FI 874804A FI 874804 A0 FI874804 A0 FI 874804A0
Authority
FI
Finland
Prior art keywords
foereningar
bicycle
bicycle foereningar
Prior art date
Application number
FI874804A
Other languages
English (en)
Other versions
FI874804A (fi
Inventor
Alban Imre Albert
Friedrich W Zilliken
Original Assignee
Zyma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zyma Sa filed Critical Zyma Sa
Publication of FI874804A0 publication Critical patent/FI874804A0/fi
Publication of FI874804A publication Critical patent/FI874804A/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
    • C07D311/64—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4 with oxygen atoms directly attached in position 8
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrane Compounds (AREA)
FI874804A 1986-11-04 1987-11-02 Bicykliska foereningar. FI874804A (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB868626344A GB8626344D0 (en) 1986-11-04 1986-11-04 Bicyclic compounds

Publications (2)

Publication Number Publication Date
FI874804A0 true FI874804A0 (fi) 1987-11-02
FI874804A FI874804A (fi) 1988-05-05

Family

ID=10606782

Family Applications (1)

Application Number Title Priority Date Filing Date
FI874804A FI874804A (fi) 1986-11-04 1987-11-02 Bicykliska foereningar.

Country Status (15)

Country Link
US (1) US4814346A (fi)
EP (1) EP0267155A3 (fi)
JP (1) JPS63130589A (fi)
KR (1) KR880006224A (fi)
AU (1) AU606087B2 (fi)
DD (1) DD275048A5 (fi)
DK (1) DK575687A (fi)
FI (1) FI874804A (fi)
GB (1) GB8626344D0 (fi)
HU (1) HUT48611A (fi)
IL (1) IL84315A0 (fi)
NO (1) NO874489L (fi)
NZ (1) NZ222411A (fi)
PT (1) PT86055B (fi)
ZA (1) ZA878245B (fi)

Families Citing this family (58)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT656786E (pt) * 1992-05-19 2004-11-30 Novogen Res Pty Ltd Utilizacao de extractos do fitoestrogenio isoflavona de soja ou trevo
US5691360A (en) * 1993-12-08 1997-11-25 Alcon Laboratories, Inc. Compounds having both potent calcium antagonist and antioxidant activity and use thereof as cytoprotective agents
US5424321A (en) * 1993-12-08 1995-06-13 Alcon Laboratories, Inc. Compounds having both potent calcium antagonist and antioxidant activity and use thereof as cytoprotective agents
PT682664E (pt) * 1993-12-08 2001-06-29 Alcon Laboratoires Inc Compostos possuindo actividade potente como antagonistas do calcio e anti-oxidantes e sua utilizacao como agentes citoprotectores
FR2731706B1 (fr) * 1995-03-14 1997-04-11 Cird Galderma Composes heterocycliques aromatiques, compositions pharmaceutiques et cosmetiques les contenant et utilisations
FR2736829B1 (fr) * 1995-07-20 1997-09-12 Oreal Composition pour lutter contre les taches et/ou le vieillissement de la peau, ses utilisations
GB9519033D0 (en) * 1995-09-18 1995-11-15 Smithkline Beecham Plc Treatment
DE19610932A1 (de) * 1996-03-20 1997-09-25 Bayer Ag 2-Aryl-substituierte Pyridine
US6207671B1 (en) * 1996-07-08 2001-03-27 Bayer Aktiengesellschaft Cycloalkano-pyridines
HRP970330B1 (en) * 1996-07-08 2004-06-30 Bayer Ag Cycloalkano pyridines
DE19627431A1 (de) * 1996-07-08 1998-01-15 Bayer Ag Heterocyclisch kondensierte Pyridine
DE19627430A1 (de) * 1996-07-08 1998-01-15 Bayer Ag Bicyclisch kondensierte Pyridine
AUPO203996A0 (en) * 1996-08-30 1996-09-26 Novogen Research Pty Ltd Therapeutic uses
US6034256A (en) * 1997-04-21 2000-03-07 G.D. Searle & Co. Substituted benzopyran derivatives for the treatment of inflammation
US6077850A (en) 1997-04-21 2000-06-20 G.D. Searle & Co. Substituted benzopyran analogs for the treatment of inflammation
US6146668A (en) 1997-04-28 2000-11-14 Novogen, Inc. Preparation of isoflavones from legumes
CA2287965C (en) * 1997-05-01 2009-10-20 Graham Edmund Kelly Treatment or prevention of menopausal symptoms and osteoporosis
AUPP112497A0 (en) * 1997-12-24 1998-01-22 Novogen Research Pty Ltd Compositions and method for protecting skin from UV induced immunosupression and skin damage
AUPP260798A0 (en) * 1998-03-26 1998-04-23 Novogen Research Pty Ltd Treatment of medical related conditions with isoflavone containing extracts of clover
AUPP868599A0 (en) * 1999-02-15 1999-03-11 Novogen Research Pty Ltd Production of isoflavone derivatives
AUPQ008299A0 (en) 1999-04-30 1999-05-27 G.J. Consultants Pty Ltd Isoflavone metabolites
AUPQ266199A0 (en) * 1999-09-06 1999-09-30 Novogen Research Pty Ltd Compositions and therapeutic methods involving isoflavones and analogues thereof
US20090233999A1 (en) * 1999-09-06 2009-09-17 Novogen Research Pty Ltd Compositions and therapeutic methods involving isoflavones and analogues thereof
AUPQ520300A0 (en) * 2000-01-21 2000-02-17 Novogen Research Pty Ltd Food product and process
AUPR363301A0 (en) 2001-03-08 2001-04-05 Novogen Research Pty Ltd Dimeric isoflavones
US20050119301A1 (en) * 2001-03-16 2005-06-02 Alan Husband Treatment of restenosis
AUPR846401A0 (en) * 2001-10-25 2001-11-15 Novogen Research Pty Ltd 6-Hydroxy isoflavones, derivatives and medicaments involving same
EP2526940A3 (en) * 2002-07-24 2014-07-30 Children's Hospital Medical Center Compositions containing enantiomeric equol, and methods for their making
US8668914B2 (en) * 2002-07-24 2014-03-11 Brigham Young University Use of equol for treating skin diseases
US7468445B2 (en) 2002-08-07 2008-12-23 University Of Mississippi Antigiardial agents and use thereof
AU2002951833A0 (en) * 2002-10-02 2002-10-24 Novogen Research Pty Ltd Compositions and therapeutic methods invloving platinum complexes
AU2003265737B2 (en) * 2002-10-02 2008-10-16 Novogen Research Pty Ltd Combination chemotherapy compositions and methods
US8580846B2 (en) 2002-10-29 2013-11-12 Brigham Young University Use of equol for ameliorating or preventing neuropsychiatric and neurodegenerative diseases or disorders
CA2504682A1 (en) 2002-10-29 2004-05-13 Colorado State University Research Foundation Use of equol for treating androgen mediated diseases
ITTO20030140U1 (it) * 2003-09-16 2005-03-17 Interfila Srl Matita cosmetica
US7514461B2 (en) 2003-09-19 2009-04-07 Edison Pharmaceuticals, Inc. Chroman derivatives
EP1740191A4 (en) * 2004-04-28 2008-07-30 Univ Brigham Young USE OF EQUOL FOR THE TREATMENT OF SKIN DISEASES
US8080675B2 (en) 2004-09-21 2011-12-20 Marshall Edwards, Inc. Chroman derivatives, medicaments and use in therapy
EP1794141B1 (en) 2004-09-21 2011-11-09 Marshall Edwards, Inc. Substituted chroman derivatives, medicaments and use in therapy
BRPI0519013A2 (pt) * 2004-12-13 2009-11-03 Lilly Co Eli composto ou esteroisÈmeros únicos, misturas de esteroisÈmeros, sais, tautÈmeros ou pró-drogas destes farmaceuticamente aceitáveis, composição farmacêutica, e, uso de um composto
JP2008531559A (ja) 2005-02-25 2008-08-14 イーライ リリー アンド カンパニー スピロ−複素環式クロマン、チオクロマン及びジヒドロキノリン
DK1888059T3 (en) 2005-06-01 2015-03-30 Edison Pharmaceuticals Inc Redox-active therapeutic products for the treatment of mitochondrial diseases and other conditions as well as modulation of energy biomarkers
US7528267B2 (en) 2005-08-01 2009-05-05 Girindus America, Inc. Method for enantioselective hydrogenation of chromenes
DK1933821T3 (da) * 2005-09-15 2020-10-26 Ptc Therapeutics Inc Halevarianter af redox-aktive terapeutika til behandling af mitokondriesygdomme og andre tilstande og modulation af energibiomarkører
EA019675B1 (ru) 2006-02-22 2014-05-30 Эдисон Фармасьютикалз, Инк. Редокс-активные терапевтические средства для лечения митохондриальных заболеваний и модуляции биомаркера коэнзима q
US20070203227A1 (en) * 2006-02-24 2007-08-30 Herman Adlercreutz Isoflavan and isoflavene compounds and their use as angiogenesis inhibitors
JP2009542626A (ja) * 2006-06-27 2009-12-03 ジャワハーラル ネール センター フォー アドヴァンスド サイエンティフィック リサーチ メチルトランスフェラーゼ（ｈｍｔａｓｅ）の部位特異的阻害剤及びその製剤方法
CN101188435B (zh) * 2007-01-08 2011-03-16 中兴通讯股份有限公司 一种比特交织装置与方法
AU2008348372A1 (en) * 2008-01-24 2009-07-30 Gilead Palo Alto, Inc. ALDH-2 inhibitors in the treatment of addiction
EP2133080A1 (de) 2008-06-13 2009-12-16 Haelan Schweiz GmbH Zusammensetzungen enthaltend Equol
EP2324003A4 (en) * 2008-07-30 2011-11-16 Novogen Res Pty Ltd 6-SUBSTITUTED ISOFLAVONOIDE COMPOUNDS AND THEIR USE
US8314153B2 (en) 2008-09-10 2012-11-20 Edison Pharmaceuticals, Inc. Treatment of pervasive developmental disorders with redox-active therapeutics
RU2585763C2 (ru) 2010-02-12 2016-06-10 Нивалис Терапьютикс,Инк. Новые ингибиторы s-нитрозоглутатионредуктазы
JP5639665B2 (ja) 2010-02-12 2014-12-10 エヌサーティー・ファーマシューティカルズ・インコーポレーテッド Ｓ−ニトロソグルタチオンレダクターゼのクロモン阻害剤
US9663484B2 (en) 2010-11-01 2017-05-30 Mei Pharma, Inc. Isoflavonoid compounds and methods for the treatment of cancer
CN116139125A (zh) 2015-02-02 2023-05-23 梅制药公司 联合治疗
CN104672192B (zh) * 2015-03-10 2017-07-28 中国药科大学 异黄酮酰胺类衍生物、其制备方法和医药用途
US10703701B2 (en) 2015-12-17 2020-07-07 Ptc Therapeutics, Inc. Fluoroalkyl, fluoroalkoxy, phenoxy, heteroaryloxy, alkoxy, and amine 1,4-benzoquinone derivatives for treatment of oxidative stress disorders

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3813415A (en) * 1972-07-28 1974-05-28 Grodziskie Zaklady Farma Polfa Process for the preparation of 3-(beta dialkylamino-ethyl)-4-alkyl-7-carboethoxymethoxycoumarins
US4157985A (en) * 1976-02-23 1979-06-12 Atlantic Richfield Company Chemical conversion method
US4264509A (en) * 1977-06-08 1981-04-28 Z-L Limited Partnership Isoflavones and related compounds, methods of preparing and using and antioxidant compositions containing same
US4218489A (en) * 1977-06-08 1980-08-19 Z-L Limited Partnership Antioxidants, antioxidant compositions and methods of preparing and using same
US4232122A (en) * 1979-01-17 1980-11-04 Z-L Limited Partnership Antioxidants, antioxidant compositions and methods of preparing and using same
US4234577A (en) * 1979-03-19 1980-11-18 Z-L Limited Partnership Ergostadientriols, compositions containing same, and methods of preparing and using same
US4368264A (en) * 1979-03-19 1983-01-11 Z-L Limited Partnership Fermentation methods of preparing ergostadientriols

Also Published As

Publication number Publication date
IL84315A0 (en) 1988-03-31
HUT48611A (en) 1989-06-28
DK575687D0 (da) 1987-11-03
JPS63130589A (ja) 1988-06-02
PT86055A (en) 1987-12-01
DD275048A5 (de) 1990-01-10
EP0267155A2 (en) 1988-05-11
AU606087B2 (en) 1991-01-31
EP0267155A3 (en) 1988-07-20
DK575687A (da) 1988-05-05
GB8626344D0 (en) 1986-12-03
NO874489D0 (no) 1987-10-28
FI874804A (fi) 1988-05-05
NO874489L (no) 1988-05-05
AU8065587A (en) 1988-05-05
NZ222411A (en) 1990-09-26
PT86055B (pt) 1990-07-31
KR880006224A (ko) 1988-07-22
US4814346A (en) 1989-03-21
ZA878245B (en) 1988-05-04

Similar Documents

Publication Publication Date Title
FI874804A (fi) Bicykliska foereningar.
DE3770402D1 (de) Motorrad.
DE3770337D1 (de) Motorrad.
IT220897Z2 (it) Motocicletta.
ATE70057T1 (de) Antitumormittel.
DE3767169D1 (de) Sportschuh.
ATE57924T1 (de) 3-aryloxy-3-substituierte-propanamine.
FI862735A0 (fi) Skyddsklaede.
DE3764043D1 (de) Alkylendiamine.
DE3884830D1 (de) Motorrad.
FI853174A0 (fi) Bicykliska foereningar.
IT8719155A0 (it) Pedale per bicicletta.
DE3779761D1 (de) Abseilgeraet.
DE3875834D1 (de) Motorrad.
DE3771918D1 (de) Chinolinamide.
FI862578A0 (fi) Automatisk reglervaexel foer fordon.
DE3771271D1 (de) Fluorphthalimide.
FI874068A0 (fi) Foerbindning foer konstruktionsdetaljer.
NO880915D0 (no) Sykkel.
DE3779382D1 (de) 3-6-diphenylpyridazine.
ES2011281B3 (es) Guardabarros.
NO871953L (no) Forbedringer vedr. roekeartikler.
DE3769536D1 (de) Kraftfahrzeugrad.
DE3860441D1 (de) Rollerbahn.
DE3763648D1 (de) Rollski.

Legal Events

Date Code Title Description
MM Patent lapsed

Owner name: ZYMA SA